Medicine & Life Sciences
Portugal
100%
Leishmaniasis
42%
Health
35%
Public Health
28%
Angola
22%
Visceral Leishmaniasis
14%
Mozambique
12%
Public Hospitals
12%
Health Policy
12%
Blood Donors
11%
Leishmania infantum
11%
European Union
11%
Occupational Groups
11%
Tuberculosis
10%
Health Services
9%
Malaria
9%
Animals
9%
Salaries and Fringe Benefits
9%
One Health
9%
Workplace Violence
9%
Azerbaijan
9%
Delivery of Health Care
9%
Lumefantrine Drug Combination Artemether
8%
Tropical Medicine
8%
Workforce
8%
Students
8%
Antimalarials
8%
Asymptomatic Infections
7%
Work Performance
7%
Health Priorities
7%
Health Care Sector
7%
Parasites
7%
Disease Outbreaks
6%
Falciparum Malaria
6%
Dengue
6%
Family Physicians
6%
Seroepidemiologic Studies
6%
Africa South of the Sahara
6%
Cross-Sectional Studies
6%
Leishmania
6%
Turkey
6%
Cabo Verde
6%
Violence
6%
Drug Resistance
6%
Private Sector
6%
Organizations
5%
Public Sector
5%
Epidemics
5%
Treatment Failure
5%
Dengue Virus
5%
Agriculture & Biology
Portugal
31%
leishmaniasis
24%
Angola
14%
malaria
12%
Leishmania infantum
10%
antimalarials
10%
questionnaires
9%
Plasmodium falciparum
9%
falciparum malaria
9%
Leishmania
8%
drug resistance
8%
artemisinin
8%
coping strategies
7%
physicians
7%
blood donors
7%
Azerbaijan
7%
Dengue virus
7%
cross-sectional studies
7%
visceral leishmaniasis
7%
infection
7%
Mozambique
7%
observational studies
7%
emerging diseases
7%
animal and human health
7%
travel
7%
health services
7%
public health
7%
dengue
7%
incidence
6%
epidemiology
6%
seroprevalence
6%
parasites
6%
European Union
6%
animals
5%
students
5%
monitoring
5%
cutaneous leishmaniasis
5%
resistance genes
5%
Turkey (country)
5%
Social Sciences
Portugal
40%
public health
27%
health
24%
incidence
12%
research policy
12%
ministry
9%
animal
9%
innovation
8%
Angola
7%
Azerbaijan
7%
health professionals
6%
coping
6%
health service
6%
animal health
6%
epidemiology
6%
personnel
5%
civil society
5%
contagious disease
5%
health authorities
5%
immigrant
5%
WHO
5%
surveillance
5%
hospital discharge
5%
resilience
5%